Sumitomo Corp SP ADR (SSUMY) 10.8500 $SSUMY Gov. Matt

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sumitomo Corp SP ADR (SSUMY) 10.8500 $SSUMY

Gov. Matt Mead on economic development tour of Asia, Europe
By BEN NEARY - AP - Tue Oct 20, 6:21PM CDT
CHEYENNE, Wyo. (AP) — Wyoming Gov. Matt Mead met with industry and government officials in Japan on the first leg of an economic development tour that will also take him to India, Germany and England this month.

Macquarie's International-Matex Refinancing Gets BBB- Rating - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 25, 12:35PM CDT
International-Matex, a subsidiary of Macquarie Infrastructure (MIC), successfully completed its refinancing of about $1.7 billion of long-term debt and revolving credit facilities, and secured an investment grade rating.
MIC: 80.58 (+0.60)

United Technology's Noresco Chosen for Energy Efficiency - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 22, 2:10PM CDT
NORESCO, a part of United Technologies Corp.'s (UTX) UTC Building & Industrial Systems, was recently selected to provide energy performance contracting (EPC) services through the WISE (Whole-building Investments for Sustainable Efficiency) program.
UTX: 108.00 (-0.50)

IIT Set to Expand New Testing Facility at Westminster - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 22, 2:00PM CDT
Premium industrial goods company ITT Corporation (ITT) lately declared its intention to expand its manufacturing operations in Westminster, South California.
ITT: 36.09 (+0.30)

GE Aviation-Woodward Form JV to Enhance Fuel Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 21, 12:30PM CDT
GE Aviation, a part of General Electric Company (GE), and industrial goods manufacturer Woodward, Inc. (WWD) recently entered into a joint venture with an equal stake to enhance fuel systems for General Electric's large commercial aircraft engine lines.
GE: 31.23 (-0.09), WWD: 62.10 (-0.01)

GE Set to Revolutionize with Digital Wind Farm Launch - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 20, 10:20AM CDT
General Electric Company (GE) recently announced the launch of its digital wind farm to address a long-standing need for greater flexibility in renewable power
GE: 31.23 (-0.09)

ITT Corporation Equips Digital Gadgets with i-ALERT 2 Monitor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 19, 3:20PM CDT
Premium industrial goods company ITT Corporation (ITT) recently launched i-ALERT 2, a machine health monitor with Bluetooth Smart capability.
ITT: 36.09 (+0.30), AAPL: 108.85 (+0.34)

Ingersoll to Gain Publicity with FEIMAFE 2015 Display - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 19, 2:55PM CDT
Ingersoll-Rand Plc (IR) recently announced that it will be exhibiting new compressor products and solutions at Latin America's largest industrial expo FEIMAFE 2015.
MIDD: 131.94 (+2.58), IR: 67.89 (+0.68), ROLL: 78.98 (+1.69)

United Technologies Prices Note Offering Worth Euro 750M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 19, 11:10AM CDT
United Technologies (UTX) successfully priced a senior note offering of Euro 750 million of senior unsecured debt, maturing on May 22, 2023.
UTX: 108.00 (-0.50)

3M Healthcare Gets Acclamation for its Green Initiatives - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 18, 2:35PM CDT
3M Healthcare, a part of 3M Company (MMM), was conferred the 2015 "Champion for Change" Award by Practice Greenhealth.
MMM: 179.77 (+0.70)

Honeywell (HON) Hits New 52-Week High on Growth Drivers - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 18, 2:25PM CDT
Shares of Honeywell International Inc. (HON) hit a new 52-week high of $106.92 during Friday's trading session.
HON: 117.01 (+0.43), CPST: 1.89 (+0.30), AOS: 95.79 (+1.14)

Honeywell's UOP Technology for the Biggest African Refinery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 14, 10:10AM CDT
Honeywell's (HON) UOP will provide process technology, catalysts and equipment to the largest refinery in Africa.
HON: 117.01 (+0.43), SORL: 2.26 (-0.05), THRM: 33.05 (+1.44)

Should Regal Beloit (RBC) Be in Your Portfolio Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 13, 2:15PM CDT
On May 13, Zacks Investment Research upgraded industrial goods manufacturer Regal Beloit Corporation (RBC) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell).
CPST: 1.89 (+0.30), RBC: 63.53 (+0.33), AOS: 95.79 (+1.14)

Regal Beloit Comfortably Beats Q1 Earnings, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 12, 9:30AM CDT
Regal Beloit Corporation (RBC) reported solid first-quarter 2015 results as earnings comfortably beat estimates with robust revenue growth.
CPST: 1.89 (+0.30), RBC: 63.53 (+0.33), AOS: 95.79 (+1.14)


Old companies thrive in brand-loyal Japan adapting to times
By YURI KAGEYAMA - AP - Mon Apr 27, 2:32AM CDT
KYOTO, Japan (AP) — Successful businesses shine for a few years, then nimbler competitors outwit them in a constant cycle that spans being feted to forgotten in less than a generation. But Japan has something different: thousands of companies that have prospered for centuries.


Texas city that prepared for oil boom now waits for bust
By EMILY SCHMALL - AP - Fri Jan 09, 2:24AM CST
SWEETWATER, Texas (AP) — Just two years ago, this Texas town known mostly for its annual rattlesnake roundup seemed to be on the brink of a transformation.
APA: 53.39 (+0.24)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading